In tumors with activated TGFβ signaling such as hepatocellular cancer, elevated SMAD4 has been shown to mediate tumor promoting signaling [26], while in other cancers such as pancreatic cancer, deletion of SMAD4 is associated with tumor progression and metastasis [27, 28]. Here, SMAD4 is linked to cancer.